< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
31 - 40 of 75
- Predictors of harmful behavior in patients undergoing bariatric surgery - a multivariate, longitudinal analysis.From2 Nov 2017 → 2 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Post-translational modification of GRP78 and its role in human Type 1 diabetesFrom1 Sep 2017 → 1 Jul 2022Funding: FWO fellowships
- Assessing the relevance of a target organ specific microRNA signature in type 1 diabetesFrom30 Jul 2017 → 20 Apr 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- The dialogue between the beta-cell and the immune system in type 1 diabetes: role of glucose-regulated protein 78 in human beta-cellsFrom1 Mar 2017 → 29 Feb 2020Funding: Foreign foundations, funds with scientific view
- Histology: a vital tool for endocrine and metabolic researchFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- The role of α-E-catenin in the control of bone mass and marrow adiposity. Implications for systemic metabolic disorders.From15 Sep 2016 → 19 Jun 2023Funding: FWO Strategic Basic Research Grant
- Development of a technology platform for next-generation cytometryFrom1 Jul 2016 → 30 Jun 2020Funding: FWO Large scale research infrastructure
- INNODIA: type 1 diabetes research.From1 Nov 2015 → 31 Oct 2023Funding: H2020-EU.2.1.-INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies (LEIT)
- The role of the post-translational modification citrullination in type 1 diabetesFrom21 Sep 2015 → 29 Jun 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of citrullination in the generation of autoantigens in type 1 diabetes.From1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
Publications
1 - 10 of 708
- The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review(2024)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 66 - 75 - CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.(2024)
Authors: Rita Derua, Chantal Mathieu, Lut Overbergh
Pages: db230588 - The double burden: Navigating type 1 diabetes and obesity(2024)
Authors: Nele Steenackers, Chantal Mathieu, Bart Van Der Schueren
- Type 1 diabetes mellitus: a brave new world(2024)
Authors: Chantal Mathieu
Pages: 71 - 72 - Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes(2024)
Authors: Kristina Casteels, Chantal Mathieu
- A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab(2024)
Authors: Chantal Mathieu
- Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes(2023)
Authors: Lieven Dupont, Natalie Lorent, Pieter Gillard, Bart Van Der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
- Neutrophils: a driving force in type 1 diabetes?(2023)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
- Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
- MULTI-OMICS TECHNOLOGIES TO IDENTIFY BIOMARKERS FOR THERAPY PREDICTION AND RESPONSE IN TYPE 1 DIABETES(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)